Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family member C19 pseudogene 2 (DNAJC19P2) is a non-protein-coding pseudogene that is homologous to the DnaJ (Hsp40) family of heat shock proteins, specifically to subfamily C member 19. As a pseudogene, DNAJC19P2 arises through retrotransposition or duplication but harbors mutations or deletions that prevent it from producing a functional protein[3][7]. Pseudogenes like DNAJC19P2 are typically considered genomic relics, although emerging research indicates some pseudogenes can have regulatory functions at the RNA level; however, there are no data suggesting DNAJC19P2 is functionally active or relevant to drug discovery or disease biology[3][5][7].
Not applicable; not targeted by any drugs due to its pseudogene status[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family member C19 pseudogene 2 (DNAJC19P2).